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Abstract 
 
The number of human milk banks is growing worldwide. The introduction of donor human 
milk (DHM) to neonatal units has been advocated as a strategy to promote maternal 
breastfeeding.  However, concern has been raised that the introduction of DHM may actually 
lead to a decrease in maternal breastfeeding. To address this question, we conducted a 
systematic literature review of studies that assessed maternal breastfeeding rates before and 
after the introduction of DHM. We searched 7 electronic databases, carried out citation 
tracking, and contacted experts in the field. Where data for breastfeeding rates before and 
after the introduction of DHM were directly comparable, a relative risk was calculated. Our 
search identified 286 studies, of which 10 met the inclusion criteria. Definitions of patient 
populations and study outcomes varied, limiting meaningful comparison.Where possible, 
relative risks (RR) were calculated on aggregated data. The introduction of DHM had a 
significant positive impact on any breastfeeding on discharge (RR 1.19, 1.06-1.35, 
p=0.005), but none on exclusive maternal breastfeeding on discharge (RR 1.12, 0.91- 1.40, 
p= 0.27) or on exclusive administration of own mother’s milk (OMM) days 1-28 of life (RR 
1.08, 0.78-1.49, p 0.65). A single centre study demonstrated a significant decrease in the 
percentage of feeds which were OMM after the introduction of DHM. In conclusion, the 
available data demonstrate some evidence of positive and negative effects on measures of 
maternal breastfeeding when DHM is introduced to a neonatal unit.  
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Introduction 
 
Donor human milk (DHM) is used in neonatal intensive care units (NICUs) for the feeding of 
preterm infants when own mother’s milk (OMM) is not available or insufficient. A recent 
Cochrane review 
1
 showed that in preterm and low birth weight infants, feeding with formula 
compared with DHM results in a higher risk of developing necrotizing enterocolitis (NEC). 
As the incidence of NEC increases in relation to the other complications of preterm birth 
2
 
there is growing interest worldwide in the use of DHM.  
 
Currently, it is estimated that there are about 500 human milk banks (HMBs) in existence in 
over 37 countries. 
3
 In addition, the number of HMBs is known to be growing in countries 
with large populations like India, 
4
 and the first HMB in Russia was recently established in 
Moscow. 
5
 DHM is currently recommended by the World Health Organization (WHO), 
6
 the 
American Academy of Pediatrics (AAP) , 
7
 and the European Society for Paediatric 
Gastroenterology Hepatology and Nutrition (ESPGHAN), 
8
 as the preferred alternative to 
OMM if this is not available for low birth weight (WHO) or preterm (AAP, ESPGHAN) 
infants. In the United States, the proportion of NICUs using DHM increased from 25% in 
2007 to 45% in 2011. 
9
 
 
Despite this, there remain many neonatal units that do not use DHM, for a variety of reasons 
including cost, uncertainty about the evidence base for its use, and parental preferences. 
10
 A 
2014 survey of level 3 and 4 NICUs in the United States 
10
 showed that that 41% of 
respondents did not use DHM for their patients. Similarly, a survey of special care baby units, 
local neonatal units and NICUs in the United Kingdom, 
11
  also carried out in 2014, showed 
that 39% of respondents did not initiate infants on DHM.   
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If the use of DHM continues to increase, a key question is how that this may impact on 
maternal breastfeeding rates. A national survey in Italy showed that neonatal units associated 
with a HMB have higher rates of maternal breastfeeding on discharge. 
12
 Using this data, 
these authors argued that the introduction of DHM may serve to extend a culture of 
breastfeeding. Similarly, others have argued that DHM should be considered a 
supportive measure to mothers expressing milk for their preterm infants, and have used 
it as part of package of measures to try to increase maternal breastfeeding rates 
13
 and 
promote a culture of using only human milk 
14
 on NICUs.  However, anecdotally, 
concerns have been raised that the introduction of DHM to a NICU may in fact discourage 
maternal breastfeeding. 
13,14
 In addition, the authors of one study have shown that 
promoting DHM can lead to an unintended decrease in the use of OMM, perhaps by 
providing an "acceptable alternative" to the initiation and maintenance of lactation. 
15
 
There is thus uncertainty as to whether the further introduction of DHM will impact 
either positively or negatively on maternal breastfeeding rates in NICUs.  
 
Two large trials in North America are currently addressing the question of whether there are 
clinical benefits to infants of using DHM compared to formula. 
16,17
 However, because these 
trials are both blinded, impacts on health professional or maternal behaviors will not be fully 
determined. Thus, the aim of this review was to strengthen the evidence base for the use of 
DHM, and to determine the effects of DHM provision on measures of OMM use during 
admission and on breastfeeding rates at discharge. We addressed the following research 
question: in mothers with an infant admitted to a neonatal unit (Population), what are the 
effects of using DHM (Intervention) versus formula milk (Comparison) on maternal 
breastfeeding rates in, and on discharge from, the NICU (Outcome). Given the complexity of 
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DHM as an intervention, we anticipated there might be relatively few randomized controlled 
trials (RCTs), and that cluster trials and/or observational studies would require research 
synthesis. 
 
Methods 
Searches 
 
This review and the manuscript reporting it was prepared according to the PRISMA 
guidelines, 
18
 and the completed PRISMA checklist is available in Supplementary Appendix 
S1. We carried out a systematic literature review in October 2014 using the following 
databases:  Medline,
19
 Embase 
20
 and Global Health 
21
 (all using the OVID interface), 
22
 The 
Cochrane Library, 
23
 CINAHL,
24
 Global Health Library, 
25
 and Current Controlled Trials. 
26
 
Search terms were generated using MESH and Emtree terms relating to breast milk, infant 
formula, milk banks, milk donation and neonatal units, with input from a medical librarian. A 
complete list of search terms, formatted for each database, is available within the study 
protocol in Supplementary Appendix S2. The review is registered on PROSPERO, 
27
 
CRD42014013162.  
 
Databases were searched from 1946 onwards. Only papers with abstracts published in the 
Latin alphabet were reviewed, and these were translated if necessary by one of the authors 
(TW). We conducted reference searches of the studies which met the inclusion criteria, 
carried out citation tracking of these studies via Google Scholar, 
28
 and contacted experts in 
the field in North America, Europe and Australia to identify further relevant studies. Two 
reviewers (TW and JS) independently assessed the papers identified in the screening search 
using the inclusion and exclusion criteria.  
Page 4 of 23
http://mc.manuscriptcentral.com/jhl
Journal of Human Lactation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
Inclusion/exclusion criteria 
 
Studies were included if 1) the study was original research, 2) the study was a controlled trial 
with participants allocated randomly, or an observational trial examining the impact on 
maternal OMM provision or breastfeeding rates pre and post introduction of DHM to a 
neonatal unit, 3) the study population was infants admitted to a neonatal unit, 4) the study 
specifically compared enteral feeding with DHM versus formula and 5) the study provided 
quantitative data on maternal breastfeeding rates during the admission or on discharge.  
Studies were excluded if the patient population included infants in postnatal or pediatric 
wards, or did not compare donor breast milk directly with formula. Study types that were 
excluded were 1) case reports or opinion pieces without primary data or 2) qualitative studies 
that did not provide data on the proportion of mothers breastfeeding during the admission or 
on discharge. 
 
Data extraction, assessment of study quality and risk of bias 
 
The following data were extracted from the studies meeting the inclusion criteria: authors, 
study setting and country where it took place, research question/study aims, definition of 
patient population, outcome measure, study sample size, rates of breast milk use prior to 
introduction of donor milk to a unit, and rates of breast milk use after the introduction of 
donor milk. Where data was given for breastfeeding rates on discharge, it was noted where 
this was on discharge from, and the definition of the time period used (eg within 48 hours of 
discharge). Data were entered onto Microsoft Excel.  
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In order to assess the risk of bias within each individual study, we applied principles from the 
Cochrane Collaboration and the Working Group for Grading of Recommendations 
Assessment, Development and Evaluation. 
29
 Modifying a scoring system used previously by 
one of us, 
30
 we assessed the quality of each study as being high, moderate, or low, according 
to study design, sample size, quality of the control group, calculation of an odds ratio/relative 
risk, confounding factors, and the geographical spread of studies. Details of the scoring 
system can be found in Supplementary Appendix S3.  
 
In order to assess the risk of bias across studies, we noted whether or not each study had been 
published in a peer reviewed journal. We contacted the principle authors of each included 
study to ascertain if they could share any unpublished data that might influence the 
cumulative evidence available. Finally, we contacted experts in the field to ensure there were 
no large datasets that were unavailable due to publication bias. 
  
Data analysis 
 
Where data for breastfeeding rates after the introduction of DHM were directly comparable 
between studies, the numbers of infants in each group were aggregated and a relative risk 
with a 95% confidence interval was calculated. 
31
 The exposure for these calculations was the 
introduction of DHM to a neonatal unit. Where data was not comparable between studies, the 
outcomes pre and post the introduction of DHM were extracted, and it was noted whether a 
summary measure had been calculated.  
 
Results 
Searches 
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Our database search yielded 374 records, and consultation with experts in the field identified 
4 further studies. Citation tracking of studies that met the inclusion criteria yielded 25 
additional records, and after excluding duplicates a total of 286 studies were screened. 
Fourteen of these studies were selected for full text review, of which 10 studies met the 
inclusion criteria (Figure 1).  Of the remaining 4, 1 was excluded as it duplicated data from 
an included study, 
32
1 was not based in a neonatal unit ,
33
 1 did not compare breastfeeding 
rates before and after the introduction of DHM, 
34
 and 1 provided no quantitative data on 
breastfeeding rates. 
35
 Six of the included studies were based in the United States 
13,14,36–38
, 2 
in Spain 
39,40
 and 1 study in the United Kingdom, 
41
 and Australia 
42
 respectively. All the 
studies were published since 2008, but included data on infants born between 2001 and 2014. 
Table 1 provides a summary of the study characteristics.  
 
Quality assessment and risk of bias 
 
The assessment of study quality is shown in Table 2. One of the studies was judged to be of 
high quality,
39
  7 of the studies were assessed to be of moderate quality, 
14,36–38,41
 and the 
remaining 2 
13,42
 to be of low quality. Only 1 study was prospective and interventional, 
14
 and 
only 2 included more than one hospital site. 
13
 Two studies included DHM as part of a bundle 
of measures designed to increase maternal breastfeeding rates 
13,14
. Six were published in peer 
reviewed journals, 
13,14,36,37,40
 and 4 were conference abstracts. 
38,41,42
 None of the contacted 
authors of the included studies shared unpublished data to contribute to our analysis. 
Consultation with experts in the field did not reveal any large unpublished data series relevant 
to this review.   
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Definitions 
 
There was substantial heterogeneity in the definition of the patient population in the included 
studies. One study looked at infants born at < 30 weeks gestation, 
42
 2 studies examined 
infants born at < 32 weeks gestation or with a birth weight (BW) of <1.5kg, 
13,40
 5 studies 
used a BW <1.5kg as the inclusion criteria, 
36–38,41,43
1 study used BW < 2 kg 
14
 and 1 study 
used BW < 1kg. 
39
  Outcome definitions were similarly heterogeneous and were comparable 
in 4 studies for any breastfeeding on discharge, 
14,39,40,43
  and in 2 studies for exclusive 
breastfeeding on discharge, 
40,42
 and exclusive administration of OMM days 1-28. 
37,40
 Only 
one study
40
 defined a time period before discharge for the receipt of breast milk (48 hours), 
and none of the studies defined how that breast milk was given on discharge. Five studies 
did not document whether all infants or only surviving infants were used as the 
denominator for measures of maternal breastfeeding; 
13,14,36,38,42,43
 3  excluded infants 
who died from their analysis , 
37,40,41
 and 1 study included these in the denominator.
39
 
When performing calculations the denominators used were those given by the authors 
and no adjustments were made for the infants who died, as these numbers were small.  
 
Studies also varied in how DHM had been introduced to a neonatal unit. Three studies looked 
at changes in the administration of OMM after the introduction of a milk bank to a neonatal 
unit. 
40–42
  Two studies examined whether there was a change in practice after the 
introduction of DHM as part of a bundle aimed to increase the use of human milk.
13,14
 One 
examined changes in practice after a new policy specifying use of DHM when not enough 
OMM was available
37
 and the remaining 4 examined changes in practice after the 
introduction of DHM to a neonatal unit. 
36,38,39,43
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Effects of introduction of DHM on maternal breastfeeding rates 
 
Two studies 
40,42
 examined the effect of the introduction of DHM on exclusive maternal 
breastfeeding rates on discharge. One of these provided no definition of “exclusive 
breastfeeding” on discharge, and the studies included two different patient population groups 
(born at < 30 weeks 
42
 vs born at <32 weeks or BW <1.5 kg).
40
 Aggregating the data showed 
no significant difference between the two groups, with a relative risk of 1.12 (CI 0.91- 1.40, 
p= 0.27) of breastfeeding on discharge after the introduction of DHM.  
 
Four studies 
14,39,40,43
  provided data on infants receiving any breastfeeding on discharge 
after the introduction of DHM. In one of these studies 
14
 DHM was introduced as part of a 
program aimed to increase the volume of human milk given to infants born at less than 2 kg. 
No significant difference (p=0.09) was found in infants receiving any breast feeds on 
discharge after the introduction of the program.  No formal definition was given of “any 
breastfeeding on discharge” in this study. Another study 
43
 found a significant increase 
(p=0.02) in any breast feeding on discharge after the introduction of DHM milk to a 
neonatal unit . Patient population groups differed between the 4 study groups (BW< 2 kg,
14
 
<1.5kg, 
43
  < 1 kg
39
 and  born at <32 weeks or BW <1.5 kg). 
40
 Aggregating the data for the 4 
studies, a significant difference was found between the two groups (relative risk: 1.19; 
CI 1.06-1.35, p=0.005), showing an increase in maternal breastfeeding after the 
introduction of DHM. 
 
Two studies 
37,40
 examined the effect of the introduction of DHM on the exclusive 
administration of OMM in the first 28 days of life. One used a patient population of infants 
born at <32 weeks
37
 and another looked at infants born at <32 weeks or with a BW < 1.5 kg. 
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40
  In the second study, there was a reduction (from 40% to 13%) in the percentage of infants 
receiving exclusive OMM. According to the authors, this was because after the introduction 
of DHM, it was used when there was not enough milk from the infants’ own mothers, 
whereas prior to the introduction of DHM, infants were fed by parenteral nutrition the first 
days of their lives to avoid infant formula. Aggregating the data, no significant difference was 
found between the two groups (RR 1.08; CI 0.78-1.49, p= 0.65). All the data above is shown 
in Supplementary Appendix S4.   
 
Single studies provided data on a number of variables related to the use of OMM after the 
introduction of DHM (Table 1). A single center study judged to be of moderate quality found 
that the introduction of DHM was associated with a significant decrease in the percentage of 
feeds which were OMM days 1-14 (p<0.01) and days 1-28  (p=0.04) of life. 
38
 One study 
examined the % of exclusive OMM given until full feeds were established 
41
 and found no 
significant difference (p=0.51) between the pre and post DHM groups. One study examined 
the % of feeds that contained >50% OMM given to infants of up to 34 weeks corrected 
gestational age, 
36
 and again found no difference between the groups (p=0.95). Two studies 
looked at the % of OMM given (as volume) for days 1-14 
13
 and 1-28 of life 
37
 respectively 
but did not calculate a statistical summary measure.  
 
Discussion 
 
Interest in the use of DHM has increased over the last decade, manifest by a worldwide 
expansion in the number of HMBs. Despite this there remains a relative lack of high quality 
research into the impact of DHM on the recipient neonatal population or its wider societal 
effects. Our systematic review of the use of DHM on maternal breastfeeding rates confirmed 
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this lack of high quality data, identifying only 10 studies that met the inclusion criteria. These 
studies were geographically limited, available from only 4 countries, and the majority of the 
included studies (6/10) were from the United States. Four of the 10 included studies were 
conference abstracts and were therefore not peer reviewed. Using a scoring system to assess 
study quality, only 1 was judged to be of high quality.  
 
The available data demonstrates mixed effects on measures of maternal breastfeeding when 
DHM is introduced to a neonatal unit. Relative risk calculations with aggregated data 
from 4 studies did show a significant increase in any breastfeeding on discharge after 
the introduction of DHM.  However, there appeared to be no effect on exclusive 
breastfeeding on discharge or the exclusive administration of OMM in the first 28 days 
of life after the introduction of DHM. Even where DHM was introduced as part of a care 
bundle (as it was in 2 of the included studies), 
13,14
 in individual centers there appeared to be 
no significant increase in measures of maternal breastfeeding. Conversely, 1 of the 10 studies 
showed a statistically significant decrease in the use of OMM after the introduction of DHM. 
38
 This was posited by the authors to be due to the fact that the provision of DHM was 
discouraging mother from expressing breastmilk. However, the remainder of the available 
evidence does not support the hypothesis that the introduction of DHM has an adverse effect 
upon breastfeeding rates in NICUs.  
 
Some of the heterogeneity in results may reflect the fact that DHM can be used in a 
variety of ways. One study described DHM as a “bridge” to be used until a mother is 
able to express enough milk for her preterm infant, 
13
 whereas others describe the 
rationale for DHM as being a way to reduce the volume of formula feeds being given to 
preterm infants 
14
 or as a means to more rapidly introduce enteral feeds. 
40
 Given that 
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DHM is introduced for a variety of reasons, and in a variety of ways (as part of package 
of measures, by opening a HMB, or by replacing preterm formula in feeding 
guidelines), it is perhaps not surprising that no consistent effect is seen on measures of 
maternal breastfeeding.  
 
Limitations 
 
Inclusion criteria and definitions of outcomes varied between the studies, precluding a 
formalized assessment of a risk of bias using a funnel plot. Where aggregated relative risks 
were calculated, study groups patient populations differed in terms of birth weight and 
gestation, and whether they included infants who had died in their denominator, 
although the number of these was small.  Our data samples were small for each variable, 
and the calculated intervals were wide, so that small but important effects in either direction 
could not be excluded for exclusive breast feeding on discharge or use of OMM in the 
first 28 days of life. For other outcomes, the heterogeneity of study variables and patient 
populations limited the ability to meta-analyse the data. We are unable to comment on 
whether having consistent definitions of patient population and study outcomes would 
have supported a positive effect of DHM on other indicators of maternal breast feeding 
success. However, it is likely that the larger data sets permitted by consistent definitions 
would have allowed a more definitive answer to the question of whether DHM impacts 
on these. 
 
Eight out of the 10 studies were retrospective, and there was a high risk of bias, with only 1 
study judged to be of high quality. We attempted to rule out publication bias by contacting 
experts in the field to see whether substantial unpublished databases existed on this topic, and 
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could not find evidence for any. However, it remains possible that reports of trials with 
negative findings have not entered peer reviewed journals or been accepted for conferences. 
In addition, we were unable to obtain unpublished data from the included studies on 
breastfeeding rates that may have influenced our results.  
 
Whilst we chose to concentrate on surrogate markers of how much OMM was provided 
during admission and on discharge, the introduction of DHM to a neonatal unit may impact 
on other important outcomes. These include rates of OMM initiation, the duration of 
provision of OMM, the total proportion of human milk (ie OMM and DHM) given to infants 
during their admission, the length of hospital admission, and practices related to the 
fortification of human milk. Thus the narrow focus of our research question may limit the 
applicability of the findings of this systematic review. 
 
 
Conclusion 
 
In summary, the available data demonstrate positive effects on some, but not all, 
measures of maternal breastfeeding rates when DHM is introduced to a neonatal unit. 
There is also some evidence that in certain settings rates might actually decrease. 
However, overall there is probably sufficient data available to re-assure clinicians that 
the introduction of DHM in itself is unlikely to adversely affect breastfeeding rates. If 
the introduction of DHM is to be promoted as a cost effective way of promoting 
maternal breastfeeding, further well designed studies with standardized populations, 
consistent use of DHM, measurable breastfeeding outcomes and economic evaluation 
may help to inform uniformity of practice. Ideally these could be integrated into large 
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randomized controlled trials looking at the effects of DHM on clinical variables such as 
mortality, NEC, sepsis and longer term health benefits. 
 
Funding Source: Funding for travel allowing the participants to meet to plan this research 
was provided by the British Association of Perinatal Medicine (BAPM). 
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Table 1: Summary of Study Characteristics 
Authors 
Study setting 
(country)  Research Question/ Study Aims 
Definition of 
patient 
population Outcome 
Study 
sample 
size Main findings 
Beasmore 
et al 
NICU (United 
Kingdom) 
Did the introduction of a HMB change 
OMM and formula milk usage during the 
establishment of enteral feeding. 
BW <1.5 kg  
% exclusive OMM 
until full enteral 
feeds achieved 
122 
65% pre vs 70% post, 
p= 0.51 
Bishop et al 
NICU (United 
States) 
To assess the influence of DHM on the 
incidence of NEC and the amount of 
OMM use.  
 BW <1.5 kg 
% of feeds that 
contained >50% 
OMM up to 34 
weeks CGA 
 331 
51% pre vs 54% post, 
p=0.95 
Delfosse et 
al  
Level 4 NICU 
(United States)  
To determine acceptance of DHM for 
feeding preterm infants and whether 
offering DHM alters OMM feeding.  
Born at < 32 
weeks or BW <1.5 
kg 
% OMM given 
(volume) days 1-
14 of life 
 650 
63% at start of 
intervention vs 60% at 
end of intervention, no 
p value calculated 
Esquerra-
Zwiers et al 
Level 4 NICU 
(United States)  
To evaluate the impact of a DHM 
program on OMM and formula feedings. 
BW <1.5 kg  
 % feeds which 
were OMM days 
1-14 of life.  
265 
85% pre vs  68% post, 
p= < 0.01 
    
% feeds which 
were OMM days 
1-28 of life. 
265 
71% pre vs 61% post, 
p= 0.04 
 Kok et al 
Neonatal Unit 
(Australia)  
The effects of the introduction of a HMB 
on the feeding of preterm infants on 
discharge. 
Born at < 30 
weeks 
Exclusive BF on 
discharge from 
neonatal unit (not 
specified further) 
 155 
53% pre vs 64% post, 
no p value calculated 
Page 19 of 23
http://mc.manuscriptcentral.com/jhl
Journal of Human Lactation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Marinelli et 
al 
 Level 4 NICU 
(United States) 
To compare enteral intake type in 
preterm infants before versus after 
establishing a DHM policy. 
BW<1.5 kg 
% OMM given 
(volume) days 1-
28 
 154 
66% pre vs 70% post, 
no p value calculated 
    
Exclusive 
administration of 
OMM days 1-28 
154 
38 % pre vs 55% post, 
no p value calculated 
Montgomery 
et al  
Level 3 NICU 
(United States) 
To assess the effects of a program 
designed to improve human milk 
availability for preterm infants on breast 
milk use and feeding-related outcomes. 
BW <2 kg 
Receiving any BF 
on discharge 
home (not 
specified further) 
  245 
44% pre vs 53% post, 
p=0.09 
Parker et al  
Level 3 NICU 
(United States) 
To determine whether rates of 
consumption of OMM at discharge 
home changed in the 2 years pre and 
post implementation of a DHM 
program. 
BW <1.5 kg 
Any BF on 
discharge from 
hospital (not 
specified further) 
154 
43% pre vs. 65% post, 
p=0.02 
Torres et al 
Neonatal Unit 
(Spain) 
To assess the impact that opening a 
HMB had on the proportion of infants 
breastfeeding at discharge and other 
practices related to feeding. 
Born at <32 
weeks or BW <1.5 
kg 
Exclusive BF on 
discharge from 
hospital (within 48 
hours of 
discharge) 
 104 
54% pre vs 56% post, 
p=0.87 
    
Any BF on 
discharge from 
hospital (within 48 
hours of 
discharge) 
104 
86% pre vs 78% post, 
p=0.27 
    
Exclusive 
administration of 
OMM days 1-28 
104 
40 % pre vs 13% post, 
no p value calculated 
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Verd et al  NICUs (Spain) 
To assess the impact of an exclusive 
human milk diet to nourish extremely 
low birth weight infants in the neonatal 
intensive care unit 
BW <1.5 kg 
Any BF on 
discharge from 
hospital (not 
specified further) 
201 
67% pre vs 70% post, 
p=0.74 
Abbreviations: NICU: Neonatal Intensive Care Unit; DHM: Donor Human Milk; OMM: Own Mother’s Milk; HMB: Human Milk Bank; BW: Birth Weight; CGA: 
Corrected Gestational Age; BF: Breastfeeding. 
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Table 2: Quality Assessment 
Authors 
Study design 
(score) 
Sample 
size 
(score) 
Quality of control 
group (score) 
Calculation 
of OR/RR 
(score) 
Confounding factors 
(score) 
Geographical spread 
(score) 
Score (quality of 
study) 
Beasmore 
et al 
Retrospective 
observational (0) 
122 (1) 
Demographic variables 
noted, no differences (2) 
Yes  (2) None (2) Data from 1 unit (0) 7 (moderate) 
Bishop et al 
Retrospective 
observational (0) 
331 (1) 
Demographic variables 
noted, no differences (2) 
Yes  (2) None (2) Data from 1 unit (0) 7 (moderate) 
Delfosse et 
al  
Retrospective 
observational (0) 
650 (2) No control group  (0) No (0) 
DHM introduced as part 
of bundle (1) 
Data from 2 units (1) 4 (low) 
Esquerra-
Zwiers et al 
Retrospective 
observational (0) 
265 (1) 
Demographic variables 
noted, no differences (2) 
Yes (2) No data (0) Data from 1 unit (0) 5 (moderate) 
 Kok et al 
Retrospective 
observational (0) 
155 (1) 
No demographic 
variables documented 
(0) 
No (0) No data (0) Data from 1 unit (0) 1 (low) 
Marinelli et 
al 
Prospective 
cohort study (1) 
154 (1) 
Demographic variables 
noted, significant 
differences (1) 
Yes (2) None (2) Data from 1 unit (0) 7 (moderate) 
Montgomery 
et al  
 Prospective 
interventional  (2) 
245 (1) 
Demographic variables 
noted, significant 
differences  (1) 
Yes (2) 
DHM introduced as part 
of bundle (1) 
Data from 1 unit (0) 7 (moderate) 
Parker et al 
Retrospective 
observational (0) 
154 (1) 
Demographic variables 
noted, no comment on 
whether significant 
differences between 
Yes (2) None (2) Data from 1 unit (0) 5 (moderate) 
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groups (0) 
Torres et al 
Retrospective 
observational (0) 
122 (1) 
Demographic variables 
documented, significant 
differences  (1) 
Yes(2) None  (2) Data from 1 unit (0) 6 (moderate) 
Verd et al 
Retrospective 
observational (0) 
201 (1) 
Demographic variables 
documented, no 
differences (2) 
Yes (2) None (2) Data from 4 units (2) 9 (high) 
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